| Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study JL Suah, M Husin, PSK Tok, BH Tng, T Thevananthan, EV Low, ... International Journal of Infectious Diseases 119, 69-76, 2022 | 66 | 2022 |
| Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection JL Suah, BH Tng, PSK Tok, M Husin, T Thevananthan, KM Peariasamy, ... Emerging microbes & infections 11 (1), 1343-1345, 2022 | 52 | 2022 |
| PICK-ing Malaysia’s epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio JL Suah, PSK Tok, SM Ong, M Husin, BH Tng, S Sivasampu, ... Vaccines 9 (12), 1381, 2021 | 44 | 2021 |
| Real-world effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection among adolescents (12 to 17-year-olds) in Malaysia M Husin, PSK Tok, JL Suah, T Thevananthan, BH Tng, KM Peariasamy, ... International Journal of Infectious Diseases 121, 55-57, 2022 | 17 | 2022 |
| Assessment of heterologous and homologous boosting with inactivated COVID-19 vaccine at 3 months compared with homologous boosting of BNT162b2 at 6 months EV Low, PSK Tok, M Husin, JL Suah, BH Tng, T Thevananthan, ... JAMA Network Open 5 (8), e2226046-e2226046, 2022 | 14 | 2022 |
